Britain Would Face 100% tariff on Pharmaceuticals Under Latest Trump Plan

Britain would face 100% tariffs on pharmaceuticals imported into the US under President Donald Trump’s latest plan, Reuters reported on Friday. Trump announced on Thursday that he was imposing a 100% tariff on pharmaceutical imports, which would apply to companies unless they establish a manufacturing presence in the US. The EU and Japan are exempt from the new tariff threat, as both negotiated trade deals that capped pharmaceutical duties at 15%, Reuters previously reported. Although Britain was the first nation to strike a trade deal with Trump, the pharmaceutical tariff rate remains under negotiation, meaning the UK is not shielded from the new measures, a source told Reuters. Pharmaceutical imports from Britain accounted for about 3.3% of total US pharmaceutical imports in 2024, according to US trade data.